» Articles » PMID: 30360450

Bioaccessibility of Marine Carotenoids

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2018 Oct 27
PMID 30360450
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The benefit of carotenoids to human health is undeniable and consequently, their use for this purpose is growing rapidly. Additionally, the nutraceutical properties of carotenoids have attracted attention of the food industry, especially in a new market area, the 'cosmeceuticals.' Marine organisms (microalgae, seaweeds, animals, etc.) are a rich source of carotenoids, with optimal properties for industrial production and biotechnological manipulation. Consequently, several papers have reviewed the analysis, characterization, extraction and determination methods, biological functions and industrial applications. But, now, the bioaccessibility and bioactivity of marine carotenoids has not been focused of any review, although important achievements have been published. The specific and diverse characteristic of the marine matrix determines the bioavailability of carotenoids, some of them unique in the nature. Considering the importance of the bioavailability not just from the health and nutritional point of view but also to the food and pharmaceutical industry, we consider that the present review responds to an actual demand.

Citing Articles

Understanding Macroalgae: A Comprehensive Exploration of Nutraceutical, Pharmaceutical, and Omics Dimensions.

Adarshan S, Sree V, Muthuramalingam P, Nambiar K, Sevanan M, Satish L Plants (Basel). 2024; 13(1).

PMID: 38202421 PMC: 10780804. DOI: 10.3390/plants13010113.


Bioaccessibility and bioactive potential of different phytochemical classes from nutraceuticals and functional foods.

Nicolescu A, Babota M, Barros L, Rocchetti G, Lucini L, Tanase C Front Nutr. 2023; 10:1184535.

PMID: 37575331 PMC: 10415696. DOI: 10.3389/fnut.2023.1184535.


Algal Carotenoids: Chemistry, Sources, and Application.

Generalic Mekinic I, Simat V, Rathod N, Hamed I, cagalj M Foods. 2023; 12(14).

PMID: 37509860 PMC: 10379930. DOI: 10.3390/foods12142768.


Marine Natural Products as Innovative Cosmetic Ingredients.

Fonseca S, Amaral M, Reis C, Custodio L Mar Drugs. 2023; 21(3).

PMID: 36976219 PMC: 10054431. DOI: 10.3390/md21030170.


Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.

Mumu M, Das A, Emran T, Mitra S, Islam F, Roy A Front Pharmacol. 2022; 13:929442.

PMID: 35983376 PMC: 9379326. DOI: 10.3389/fphar.2022.929442.


References
1.
Wang Y, Chung S, McCullough M, Song W, Fernandez M, Koo S . Dietary carotenoids are associated with cardiovascular disease risk biomarkers mediated by serum carotenoid concentrations. J Nutr. 2014; 144(7):1067-74. DOI: 10.3945/jn.113.184317. View

2.
Park J, Chyun J, Kim Y, Line L, Chew B . Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond). 2010; 7:18. PMC: 2845588. DOI: 10.1186/1743-7075-7-18. View

3.
Augusti P, Quatrin A, Somacal S, Conterato G, Sobieski R, Ruviaro A . Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits. J Clin Biochem Nutr. 2012; 51(1):42-9. PMC: 3391862. DOI: 10.3164/jcbn.11-74. View

4.
Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W . Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb. 2001; 7(4):216-22. DOI: 10.5551/jat1994.7.216. View

5.
Osterlie M, Bjerkeng B . Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem. 2000; 11(10):482-90. DOI: 10.1016/s0955-2863(00)00104-2. View